CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 316 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,419,000 | +51.0% | 14,100 | -0.5% | 0.27% | +47.5% |
| Q3 2014 | $940,000 | -7.9% | 14,170 | -3.1% | 0.18% | -2.7% |
| Q2 2014 | $1,021,000 | -7.4% | 14,625 | -3.0% | 0.19% | -8.8% |
| Q1 2014 | $1,103,000 | -8.2% | 15,075 | -13.6% | 0.20% | -10.9% |
| Q4 2013 | $1,202,000 | +0.1% | 17,455 | -7.7% | 0.23% | -6.5% |
| Q3 2013 | $1,201,000 | +17.2% | 18,905 | -11.0% | 0.24% | +14.5% |
| Q2 2013 | $1,025,000 | – | 21,230 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
| HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
| SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
| Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
| PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
| Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
| Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |